Approval · Notice of Compliance 3794 · 1997
RENEDIL: Notice of Compliance 3794
Issued April 22, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3794
- Date
- April 22, 1997
- Company
- Hoechst Marion Roussel Canada Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Admin
- Reason
- New tablet size
- Therapeutic class
- Antihypertensive agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RENEDIL | Not yet assigned | — |
Medicinal ingredients
- FELODIPINE 5 MG per TAB
- FELODIPINE 10 MG per TAB